Command Palette

Search for a command to run...

Preprint WatchModerateAugust 1st, 2026

Exploratory Network Analysis of Oral Bacteria Taste Signaling Autophagy Crosstalk in Oral Squamous Cell Carcinoma and Multi-Target Ligand Design for the MAPK1 STAT3 mTOR Axis

Akhavan, M.; Latifi-Navid, S. G.; Barzegar Behrooz, A.; Vakili, S.; Vitorino, R.; Aftabi, S.; Peela, S.; Ponamgi, S.; Schroth, R. J.; Berumen, M.; Yuan, C.; Akbari Azirani, T.; Pecic, S.; Chelikani, P.; Ghavami, S.

Network analysis of bacteria-associated host interaction data suggests that taste-associated GPCR signalling converges on a MAPK1 centred axis linking calcium signalling, autophagy and STAT3 or mTOR crosstalk in oral squamous cell carcinoma, with multi-target ligands proposed against that axis.

Moderate contradiction

1 prior failure

Two documented clinical failures match this mechanism, or a single Phase 3 failure is on record.

Claidex records one MAPK1 failure, the ulixertinib Phase 2 in metastatic uveal melanoma that stopped for lack of efficacy (ulixertinib-mapk1-erk-metastatic-uveal-melanoma-phase2-efficacy-failure). That trial tested direct ERK inhibition in a tumour with constitutive upstream pathway activation. This preprint is computational and proposes MAPK1 as one node in a multi-target ligand strategy rather than as a single point of intervention, which is a weaker claim than the one ulixertinib tested. No experimental validation of the proposed ligands is reported, so the flag records the recurrence of MAPK1 as a nominated target in a new indication rather than new evidence for or against the node. Data note: at run time on 1 August 2026 this DOI did not yet resolve through doi.org (HTTP 404), although the record is live in the bioRxiv API and at https://www.biorxiv.org/content/10.64898/2026.07.30.741861v1. The DOI registration lag is expected to clear.

Abstract excerpt

G protein-coupled receptor (GPCR) signaling represents a critical interface between oral bacteria and host cellular regulation in oral squamous cell carcinoma (OSCC). Here, we integrated systems biology, exploratory machine learning, and structure-based drug design to characterize potential associations between bacteria related signaling and autophagy and to identify candidate therapeutic targets. Taste associated signaling genes belonging to the GPCR superfamily were curated from KEGG, while OSCC and autophagy-associated proteins were obtained from STRING, Reactome, UniProt, KEGG, and HMDB. Ten bacteria-associated host-interaction datasets were integrated using NetworkAnalyst to construct protein protein interaction networks, and key hub nodes were identified through degree and betweenness centrality. Feature matrices derived from network topology were analyzed using exploratory dimensionality reduction (PCA), hierarchical clustering, and supervised models (SVM and Gradient Boosting) to assess whether network derived features showed separability according to literature informed bacterial reference categories; a Dysbiosis Index was additionally calculated. Results suggested that bacterial sensing through taste-associated GPCR signaling may converge on a MAPK1 centered axis linking calcium signaling, autophagy, and oncogenic pathways. Pathobiont-associated networks showed greater representation of inflammatory and terminal-autophagy-related signaling through MAPK1 STAT3, whereas commensal-associated networks were more closely aligned with cytoprotective autophagy through balanced MAPK1 TP53/PTEN networks. Exploratory machine learning analyses highlighted MDM2 and AKT3 as high contribution, network-associated candidate features linked to group separability within the current dataset. A dual target MTDL (SG101) was designed to target downstream nodes (MDM2 and JAK2), showing favorable predicted docking interactions and computationally predicted ADMET properties. In conclusion, bacteria-associated host taste signaling may be linked to differing autophagy-related network states in OSCC, and targeting downstream regulatory hubs with multi-target ligands represents a hypothesis-generating strategy that warrants experimental validation for pathway oriented therapy.

Matching Claidex post-mortems

1 of 1 indexed

This is an automated contradiction flag, not an editorial judgment on the preprint's quality. Flags identify where the preclinical literature and the clinical failure record diverge.